GSK3B and Alzheimer disease: Thus, 3t could be evaluated in other targets, such as glycogen synthase kinase-3β (GSK-3β), as it has been reported that 1-aryl-3-benzylureas acts as GSK-3β inhibitors [45] and GSK-3β has also been used as a target for designing multitarget compounds for AD [46].